title: Lorcaserin for weight loss: insights into US Food and Drug Administration approval.
authors.affiliation: Miller Scientific Consulting, Inc, Arden, NC 28704, USA. larry@millerscientific.com
authors.forename: Larry E
authors.initials: LE
authors.lastname: Miller
mesh_terms: D019440:Anti-Obesity Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001552:Benzazepines / Q000009:adverse effects / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D009765:Obesity / Q000188:drug therapy* / Q000453:epidemiology; D058826:Serotonin 5-HT2 Receptor Agonists / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D019440:Anti-Obesity Agents; D001552:Benzazepines; D058826:Serotonin 5-HT2 Receptor Agonists; C506658:lorcaserin